Evidence of orbital B and T cell depletion after rituximab therapy in Graves' ophthalmopathy.
Nielsen
Jacob F
JF
El Fassi
Daniel
D
Nielsen
Claus H
CH
Hegedüs
Laszlo
L
Lauer
Simeon A
SA
Silkiss
Rona Z
RZ
Prause
Jan U
JU
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D001402:B-Lymphocytes / Q000473:pathology*; D049970:Graves Ophthalmopathy / Q000188:drug therapy* / Q000473:pathology*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008212:Lymphocyte Depletion; D009915:Orbit / Q000473:pathology*; D000069283:Rituximab; D013601:T-Lymphocytes / Q000473:pathology*
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab